What Are the Challenges Faced by Cytimmune Sciences?
Despite the potential benefits, there are several challenges in developing nanoparticle-based therapies:
Regulatory Approval: The regulatory pathway for nanomedicines is complex and requires extensive testing to ensure safety and efficacy. Manufacturing Scale-Up: Producing nanoparticles at a commercial scale while maintaining quality and consistency is a significant challenge. Biocompatibility: Ensuring that nanoparticles are biocompatible and do not elicit adverse immune responses is crucial. Cost: Developing and manufacturing nanoparticle-based therapies can be expensive, which may limit their accessibility.
